Richard Faust

A meta-analysis of studies looking at coffee consumption and prostate cancer risk has found higher consumption linked to lower overall risk and even greater reductions for advanced prostate cancer and...

Dr. Daniel P. Petrylak, MD spoke of poly(ADP-ribose) polymerase (PARP) inhibitors having the potential to change the standard of care for prostate cancer (PCa) at the 13th Annual Interdisciplinary Prostate...

Not long ago I wrote an article on Axumin, a radioactive injection used in conjunction with a PET scan, and its potential to improve the detection and location of recurrent...

Cleveland Diagnostics, Inc. announced that its IsoPSA prostate cancer diagnostic test was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This program is “for certain medical...

It has been possible for years to use the PSA test and its findings as a potential warning sign of prostate cancer recurrence, but harder to detect specifically where the...